Distribution of Mycobacterium tuberculosis Lineages and Drug Resistance in Upper Myanmar
Issued Date
2022-12-01
Resource Type
eISSN
24146366
Scopus ID
2-s2.0-85144644412
Journal Title
Tropical Medicine and Infectious Disease
Volume
7
Issue
12
Rights Holder(s)
SCOPUS
Bibliographic Citation
Tropical Medicine and Infectious Disease Vol.7 No.12 (2022)
Suggested Citation
Phyu A.N., Aung S.T., Palittapongarnpim P., Htet K.K.K., Mahasirimongkol S., Aung H.L., Chaiprasert A., Chongsuvivatwong V. Distribution of Mycobacterium tuberculosis Lineages and Drug Resistance in Upper Myanmar. Tropical Medicine and Infectious Disease Vol.7 No.12 (2022). doi:10.3390/tropicalmed7120448 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/84835
Title
Distribution of Mycobacterium tuberculosis Lineages and Drug Resistance in Upper Myanmar
Other Contributor(s)
Abstract
Mycobacterium tuberculosis complex (MTBC) is divided into 9 whole genome sequencing (WGS) lineages. Among them, lineages 1–4 are widely distributed. Multi-drug resistant tuberculosis (MDR-TB) is a major public health threat. For effective TB control, there is a need to obtain genetic information on lineages of Mycobacterium tuberculosis (Mtb) and to understand distribution of lineages and drug resistance. This study aimed to describe the distribution of major lineages and drug resistance patterns of Mtb in Upper Myanmar. This was a cross-sectional study conducted with 506 sequenced isolates. We found that the most common lineage was lineage 2 (n = 223, 44.1%). The most common drug resistance mutation found was streptomycin (n = 44, 8.7%). Lineage 2 showed a higher number of MDR-TB compared to other lineages. There were significant associations between lineages of Mtb and drug resistance patterns, and between lineages and geographical locations of Upper Myanmar (p value < 0.001). This information on the distribution of Mtb lineages across the geographical areas will support a lot for the better understanding of TB transmission and control in Myanmar and other neighboring countries. Therefore, closer collaboration in cross border tuberculosis control is recommended.